Private equity firm Clayton, Dubilier & Rice (CDR) has agreed to buy London-listed UDG Healthcare for 2.6 billion pounds ($3.7 billion), the pharmaceuticals services company said on Wednesday.
CDR has agreed to pay 10.23 pounds in cash per share in UDG, a premium of 21.5% on Tuesday’s close.
Read more/Source: Reuters
Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.